Results 41 to 50 of about 355,394 (341)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Urine Drug Test Interpretation: An Educational Program's Impact on Resident Knowledge and Comfort Level

open access: yesMedEdPORTAL, 2018
Introduction Following the release of the Centers for Disease Control and Prevention guidelines in 2016, institutions are encouraged to have controlled substance agreements that require the use of drug screens for appropriate opioid prescribing.
Whitney Aultman   +4 more
doaj   +1 more source

Financial Burden Associated With Hospitalisation Among Families of Childhood Brain Tumours in Australia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Families of children with cancer experience significant financial strain, even with universal healthcare. Indirect costs, such as productivity losses and non‐medical expenses, are rarely included in economic evaluations, and little is known about how effectively financial aid programmes alleviate this burden. Childhood brain tumours
Megumi Lim   +8 more
wiley   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Self-assessment in the implementation of pharmaceutical care in Indonesian hospitals [PDF]

open access: yes, 2018
— Background: Pharmaceutical care is regarded as the process of optimizing the outcome of a patient’s drug therapy, thus improving the patient’s quality of life.
Setiadi, Antonius Adji Prayitno   +3 more
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation

open access: yesBMC Health Services Research, 2020
Background Pharmaceutical care services have been recognized as the most highly regarded professional pharmacy practice model that allows the identification, intervention, and resolution of drug related problems.
Barbara Barros Silva, Claudia Fegadolli
doaj   +1 more source

Pharmaceutical care for elderly patients shared between community pharmacists and general practitioners: A randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128] [PDF]

open access: yes, 2004
Background: This trial aims to investigate the effectiveness and cost implications of 'pharmaceutical care' provided by community pharmacists to elderly patients in the community.
Campion, P   +10 more
core  

Patient safety: are we maximizing the potential of the pharmacist's role? [Editorial] [PDF]

open access: yes, 2009
Original article can be found at: http://www.medicinescomplete.com/journals/ijpp/current/ Copyright Pharmaceutical Press.Peer ...
Dhillon, S.
core   +1 more source

A Method of Evaluating Pharmaceutical Care Services

open access: yesIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2005
Since 1988, hospital pharmacists in Japan have been developing clinical pharmacy services for inpatients whose aims are to promote proper drug use and effective risk management. Health insurance reimbursement fees for inpatient pharmaceutical care services have increased tremendously since 1988 and this indicates that pharmaceutical care services are ...
Doolin Eiko Nakata   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy